Mark Grinstaff, Ph.D.
Professor (BME, Chemistry)
Professor (BME, Chemistry)
- Primary Appointment Professor (BME, Chemistry)
- Education B.A., Occidental College, 1987
Ph.D., University of Illinois at Urbana-Champaign, 1992
- Additional Affiliations Professor, Materials Science and Engineering
- Honors and Awards National Academy of Inventors Charter Fellow, 2012
Kern Faculty Fellow, 2012
Stevenson Biomaterials Lecturer, Syracuse Biomaterials Institute, Syracuse University, 2011
Boston University Innovator of the Year, 2010
Elected to the College of Fellows of the American Institute for Medical and Biomedical Engineering (AIMBE), 2010
Professeur Invité and Certificat sur Honneur, Université de Bordeaux (Bordeaux II), 2010
COE Distinguished Faculty Fellow (5-year Endowed Fellowship), 2009
Edward M. Kennedy Award for Health Care Innovation, 2008
Professeurr Invité and Certificat sur Honneur, Université de la Maditerranée (Aix-Marseille II), 2007
Elected Fellow of the American Academy of Nanomedicine, 2006
Johnson and Johnson Focused Giving Grant Recipient, 2001
3M Non-Tenured Faculty Award, 2001
Alfred P. Sloan Research Fellowship, 2000
Camille Dreyfus Teacher-Scholar, 2000
Pew Scholar in the Biomedical Sciences, 1999
NSF Career Award, 1999
Whitaker Foundation Grant Recipient, 1998
ACS Nobel Laureate Signature Award, 1994
NIH Postdoctoral Fellowship, 1993
T.S. Piper Award for Outstanding Inorganic Research, 1991
The ACS Fellowship of the Colloid & Surface Division (Sponsored by Procter & Gamble), 1990
University of Illinois Chemistry Department Fellowship, 1989
- Areas of Interest Polymers, biomaterials, nanomaterials, wound repair, tissue engineering.
- Research Areas The Grinstaff Group pursues highly interdisciplinary research in the areas of biological and macromolecular chemistry. The major goal in these research projects is to elucidate the underlying fundamental chemistry and engineering principles and to use that insight to direct our creative and scientific efforts.
We are designing, synthesizing, and characterizing novel dendrimers, termed “biodendrimers,” for tissue engineering and biotechnological applications. Currently, we are evaluating these novel biomaterials for the repair of corneal lacerations, for the delivery of anti-cancer drugs, for the delivery of DNA, and as temporary biodegradable scaffolds for cartilage repair.
We are creating novel polymeric coatings termed “interfacial biomaterials” that control biology on plastic, metal, and ceramic surfaces.
We are designing electrochemical-based sensors/devices using conducting polymer nanostructures and specific DNA structural motifs.